Regarding biomarkers in CSF, higher levels of t-tau, p-tau, and Aβ42/t-tau ratio, and lower levels of Aβ42 and Aβ42/Aβ40 ratio, were observed in the AD groups. Here, MAPT is linked to Alzheimer disease.